Mohamed Kamal
Overview
Explore the profile of Mohamed Kamal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
443
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sabry I, Zeineldin M, Kamal M, Hefnawy A, El-Attar H, Abdelraof Y, et al.
Trop Anim Health Prod
. 2025 Feb;
57(2):78.
PMID: 39998594
The advent of next-generation sequencing technologies has uncovered the importance of commensal microbial populations in the lower respiratory tract (LRT) for mucosal health and their role in the development of...
2.
Zakaria M, Shalaby N, Talaat F, Elmazny A, Hamdy E, Swelam M, et al.
Mult Scler Relat Disord
. 2025 Jan;
94:106278.
PMID: 39854856
Background: Relapsing-remitting MS (RRMS) exhibits significant heterogeneity and different treatment responses. Up to date, there is no international consensus on defining disease activity which foretells potential prognosis. This study aims...
3.
Maher E, Kamal M, El-Ayadi M, Refaat A, Enayet A, El-Beltagy M, et al.
Cancer Epidemiol Biomarkers Prev
. 2024 Dec;
34(3):420-427.
PMID: 39688610
Background: Central nervous system (CNS) tumors are the leading cause of cancer-related deaths in children. Although most cases come from low- and middle-income countries (LMIC) where their prognosis is worse,...
4.
Schmidt M, Naghdloo A, Prabakar R, Kamal M, Cadaneanu R, Garraway I, et al.
Oncogene
. 2024 Nov;
44(7):439-449.
PMID: 39578659
Therapeutic resistance in cancer significantly contributes to mortality, with many patients eventually experiencing recurrence after initial treatment responses. Recent studies have identified therapy-resistant large polyploid cancer cells in patient tissues,...
5.
Mustafa M, Amawi M, Altoonisi M, Soliman W, Kamal M, Asaad Z, et al.
Cureus
. 2024 Nov;
16(10):e70871.
PMID: 39497863
Sickle cell anemia (SCA) is a genetic disorder characterized by the production of abnormal hemoglobin S, leading to red blood cell sickling and subsequent vaso-occlusive events. Neurological complications, particularly strokes,...
6.
Hicks J, Schmidt M, Nahgdloo A, Prabakar R, Kamal M, Cadaneanu R, et al.
Res Sq
. 2024 Nov;
PMID: 39483900
Therapeutic resistance in cancer significantly contributes to mortality, with many patients eventually experiencing recurrence after initial treatment responses. Recent studies have identified therapy-resistant large polyploid cancer cells in patient tissues,...
7.
Schmidt M, Naghdloo A, Prabakar R, Kamal M, Cadaneanu R, Garraway I, et al.
bioRxiv
. 2024 Sep;
PMID: 39229204
Therapeutic resistance in cancer significantly contributes to mortality, with many patients eventually experiencing recurrence after initial treatment responses. Recent studies have identified therapy-resistant large polyploid cancer cells in patient tissues,...
8.
ElShereef C, Zaki H, Badary O, Kamal S, Nagy M, Makhlouf D, et al.
Asian Pac J Cancer Prev
. 2024 Jul;
25(7):2445-2455.
PMID: 39068579
Objectives: Rhabdomyosarcoma (RMS) accounts for 50% of soft tissue sarcomas and 7% of pediatric malignancies. Cyclophosphamide (CPA) is the cornerstone of therapy and is a prodrug that is activated by...
9.
Kamal M, Nagy M, Hassanain O
Per Med
. 2024 Jul;
21(3):151-161.
PMID: 39051663
The application of personalized medicine in developing countries is a major challenge, especially for those with poor economic status. A critical factor in improving the application of personalized medicine is...
10.
Zaghloul M, Alnagmy A, Kasem H, Hakim M, Abdallah A, Kamal M, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jun;
120(3):658-666.
PMID: 38879088
Purpose: Adjuvant radiation therapy (ART) after radical cystectomy in locally advanced bladder cancer was revived after the advancement in precise radiation therapy that decreased the normal pelvic tissue radiation hazards....